Corporate information

Official name
NBE-Therapeutics AG
Registration country

Company type

Biotech company focused on developing antibody-based treatments for cancer patients.

Funding rounds

Series B CHF 20,000,000


USD 20,500,000 ( )

Profile Country Notes
PPF Group Led the round.
Boehringer Ingelheim Venture Fund GmbH (BIVF)


Investment activity status
Active investor

Current team

Past employees

Selected Products / Customers

Financials